We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron’s Antibody Cocktail Appears Effective in Hospitalized COVID Patients
Regeneron’s Antibody Cocktail Appears Effective in Hospitalized COVID Patients
Regeneron has released positive initial results from an ongoing phase 1/2/3 study evaluating its antibody cocktail, casirivimab and imdevimab, in hospitalized COVID-19 patients who require low-flow oxygen.